Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2025-12-24 @ 1:29 PM
NCT ID: NCT05375695
Eligibility Criteria: Inclusion Criteria: * Age: ≥18 years * Overweight or obesity (BMI ≥25 kg/m2) * T2D with HbA1c \>53 mmol/mol * Habitual eating window ≥12 h/day (incl. foods/snacks and energy-containing beverages) * Associated with the T2D clinic at Steno Diabetes Center Copenhagen (SDCC) or Hvidovre Hospital Exclusion Criteria: * Weight loss \>5kg last 3 months * Bariatric surgery or planned bariatric surgery within study duration * Use of fast acting insulin and combination insulin products * Unable or unwilling to adhere to time-restricted eating; for instance, due to competing medical conditions. * A wish to adhere to Ramadan * For women: current/planned pregnancy or lactation * Alcohol or drug abuse (judged by investigator) or treatment with disulfiram * Severe hypoglycaemia within last year (Severe hypoglycaemia, as defined by the American Diabetes Association, denotes severe cognitive impairment requiring external assistance for recovery) * Inability to understand written and oral information in Danish. * Diagnosed with an eating disorder in the past 3 years * Medical condition which, based on investigators assessment, challenges participation including but not limited to severe heart, vascular or lung disease, cancer, chemotherapy, psychiatric gastrointestinal, rheumatic or endocrine diseases etc. * Concomitant participation in other intervention study
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT05375695
Study Brief:
Protocol Section: NCT05375695